


Ferryx Revenue
Biotechnology Research • Bristol, England, United Kingdom • 1-10 Employees
Ferryx revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,100,000 |
| Total funding | $415,500 |
Key Contact at Ferryx
Jenny Bailey Cooper
Chief Executive Officer and Co-Founder
Company overview
| Headquarters | Bristol, England, United Kingdom |
| Website | |
| NAICS | 541714 |
| Keywords | Probiotics, Food Supplements, Consumer Healthcare |
| Founded | 2019 |
| Employees | 1-10 |
| Socials |
About Ferryx
Ferryx is a biotechnology company developing next generation probiotics that work during inflammation or stress, which most probiotics can't. Our lead product, Ferrocalm, is a scientifically validated supplement designed to support gut health, particularly for people with irritable bowel syndrome (IBS). Ferrocalm is the first probiotic designed to work during IBS flare-ups, not just in between. Backed by science, it helps reduce symptoms right when they're at their worst.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Ferryx has 1 employees across 1 departments.
Departments
Number of employees
Frequently asked questions
4.8
40,000 users



